Eubel Brady & Suttman Asset Management Inc Amgen Inc Transaction History

Eubel Brady & Suttman Asset Management Inc

  • $691 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
SELL
$212.27 - $248.7 $75,355 - $88,288
-355 Closed
0 $0
Q2 2021

Aug 17, 2021
BUY
$233.58 - $259.14 $82,920 - $91,994
355 New
355 $88,000
Q1 2020

May 13, 2020
SELL
$182.24 - $241.7 $2.26 Million - $3 Million
-12,409 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$189.21 - $243.2 $2.35 Million - $3.02 Million
12,409 New
12,409 $98,000

Others Institutions Holding AMGN

# of Institutions
3,075
Shares Held
417M
Call Options Held
7.19M
Put Options Held
6.28M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Eubel Brady & Suttman Asset Management Inc Portfolio

Follow Eubel Brady & Suttman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eubel Brady & Suttman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eubel Brady & Suttman Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email